Silica scaling is a major challenge in the application of high-pressure reverse osmosis (RO) membranes. In this work, we modified commercially available RO membranes by grafting different sulfonic acid monomers onto their surface using redox polymerization. We systematically studied the effects of various sulfonic acid monomers on membrane performance. Due to the different grafting abilities of sulfonic acid monomers on the membrane, the modified membranes exhibited different physicochemical properties. Simulated silica scaling experiments revealed that the initial permeate flux and sulfonic acid grafting rate of the membrane played crucial roles in its antifouling performance. Molecular dynamics (MD) simulation indicated that the adsorption of silica scale on the membrane was positively correlated with the grafting degree of sulfonic acid monomers. The membrane modified with 3-sulfopropyl potassium methacrylate (SPM) demonstrated a 14 % higher initial flux than the pristine membrane and the highest sulfonic acid grafting rate, resulting in the lowest flux decay rate. Additionally, the SPM modified membrane outperformed the pristine membrane against composite foulants with organic matters and silica. Our research demonstrated that the redox grafting polymerization of sulfonic acid monomers can simultaneously improve the flux and silica scaling resistance of RO membranes without compromising salt rejection. This provides a scalable strategy for preparing RO membranes with enhanced resistance to silica scaling.
A novel hydrophobic association copolymer (PAMA) was synthesized by incorporating acrylamide (AM), 2-acrylamide-2-methylpropanesulfonic acid (AMPS), cationic monomer (MEDDA), and methyl methacrylate (MMA). The properties of MMA copolymers with varying contents were analyzed using infrared spectroscopy, nuclear magnetic resonance spectroscopy, and scanning electron microscopy. Optimal overall performance of the solution was achieved when the MMA content reached 1.4 % w/w. Compared to pure PAAM (without MMA), the PAMA-1.4 % polymer exhibited superior viscoelasticity, temperature resistance, and shear resistance. This enhancement in PAMA performance can be attributed to the significant inhibition of intermolecular water film formation within the polymer matrix by MMA, effectively improving and regulating solution solubility while strengthening molecular chain interactions and enhancing the structural network strength of PAMA polymers. Additionally, the inclusion of MMA transformed rock surfaces from non-wetting to wetting conditions, thereby greatly improving oil displacement efficiency. In displacement experiments, PAMA-1.4 % performed better in terms of enhanced oil recovery, the recovery rate of 0.1 % w/w PAMA-2.4 % solution is only 7.78 %, while the recovery rate of 0.1 % w/w PAMA-1.4 % solution is 13.06 %.
Gaoyang Guo,Linhe Jin,Binggang Wu,Haiyang He,Fan Yang,Liangpeng Xu,Yang Lei,Yunbing Wang
With the coming of an aging society and the emergence of transcatheter valve technology, the implantation of bioprosthetic heart valves (BHVs) in patients with valvular disease has significantly increased worldwide. Currently, most clinically available BHVs are crosslinked with glutaraldehyde (GLUT). However, the GLUT treated BHV is less durable due to the combined effect of multiple factors such as cytotoxicity, immune responses, and calcification. In this study, the in-situ polymerization of sulfonic monomers with a decellularized extracellular matrix (ECM) was performed to simultaneously achieve the crosslinking and functionalization of ECM. Subsequently, the feasibility of the hybrid ECM used as leaflet material of BHV was evaluated. In in-vitro tests, the results indicated that the hybrid ECM fixed collagen efficiently and the introduction of sulfonic polymer promoted the proliferation and migration of human umbilical vein endothelial cells (HUVECs). In in-vivo tests, after being implanted in SD rats and mice, the hybrid ECM significantly inhibited immune response and calcification compared with the non-hybrid counterpart and GLUT crosslinked tissue. These results indicated that the hybrid ECM exhibited more competitive stability and better biocompatibility compared to these features in GLUT-crosslinked valve. Therefore, the sulfonic polymer hybrid ECM provides a potential material for more durable BHV and the in-situ polymerization strategy can serve as a general treatment method for tissue crosslinking as well as tailoring the biophysical properties of ECM.
危险品化学品经营许可证（带存储）